Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Zhi ping Jiang"'
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 7, Iss 6, Pp 374-380 (2017)
A sensitive, rapid, simple and economical ultra-performance liquid chromatographyâtandem mass spectrometric method (UPLCâMS/MS) was developed and validated for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma using gl
Externí odkaz:
https://doaj.org/article/1d00fdcb2ba94d83937378b0587d2719
Publikováno v:
Cailiao Baohu, Vol 55, Iss 2, Pp 145-159 (2022)
Due to the unique structure and high water repellency of surface of superhydrophobic materials, when superhydrophobic coating is applied on metal materials, it can prevent the metal substrate from contacting corrosive medium and therefore, largely im
Externí odkaz:
https://doaj.org/article/c5f373ecbf1f47eeb2f98a62d4e0d3be
Autor:
Qing Wang, Zhi-Ping Jiang, Jing Zeng, Yan Zhu, Hua-Lin Cai, Da-Xiong Xiang, Qun He, Xiao-Liu Shi, An-Ni Zhong, Xie-Lan Zhao, Ping Xu
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 23, Iss 1 (2020)
Purpose: We investigated the relationship between imatinib trough concentrations and genetic polymorphisms with efficacy of imatinib in Chinese patients with chronic myeloid leukemia (CML). Methods: There were 171 eligible patients. Peripheral blood
Externí odkaz:
https://doaj.org/article/136b081e766e4cd59a29f9722d206214
Autor:
Lu Wang, Yu Xuan Jiang, Zhan Wang, Qi En Huo, Jie Dai, Sheng Long Xie, Rui Li, Ming Tao Feng, Yue Shen Xu, Zhi Ping Jiang
Publikováno v:
Journal of Software: Evolution and Process.
Autor:
Zhi-Ping Jiang, Wei Zhang, Fang Yuan, Gan Zhou, Cao Shan, Cong Cheng, Xie-Lan Zhao, Hong-Hao Zhou, Xiao-Ping Chen
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 111652-(2021)
Chemotherapy resistance remains to be the primary barrier to acute myeloid leukemia (AML) treatment failure. Nuclear factor-erythroid 2-related factor 2 (Nrf2) has been well established as a truly pleiotropic transcription factor. Inhibition of Nrf2
Autor:
An-Ni Zhong, Yi Yin, Bing-Jie Tang, Lei Chen, Hong-Wei Shen, Zhi-Ping Tan, Wen-Qun Li, Qun He, Bao Sun, Yan Zhu, Jie Xiao, Zhi-Ping Jiang, Ping Xu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: CircRNA has appeared as a critical molecular in the development of various cancers. However, the cellular function of circRNAs and exosomal circRNAs has not been well explored in Chronic myeloid leukemia (CML). Methods: Differentially exp
Publikováno v:
Acta Astronautica. 160:206-215
The effect of the penetration mode on the thermal protection system by opposing jet is studied in this paper. The results show that the opposing jet not only pushes the bow shock away from the blunt body and reduces the shock intensity, but also dire
Autor:
Jing Zeng, Zheng Jiao, Hua-Lin Cai, Qing Wang, Er-Qian Yu, Ping Xu, Zhi-Ping Jiang, Xie-Lan Zhao, Hoan Linh Banh, Miao Yan, Yan Zhu, Da-Xiong Xiang
Publikováno v:
Pharmacogenomics. 20:251-260
Aim: This study aimed to establish a population pharmacokinetic (PPK) model in Chinese patients with chronic myeloid leukemia, and to quantify the effects of pharmacogenetics on pharmacokinetic parameters of imatinib. Methods: A total of 229 plasma c
Autor:
Yue Shi, Li Dong, Zhuangzhuang Li, Xiaoyan Chang, Zhi-Ping Jiang, Wei-Yi Jin, Jiashuo Wu, Hong Sun, Jia-Wen Shi
Publikováno v:
Journal of ethnopharmacology. 266
Ethnopharmacological relevance Irinotecan (CPT-11) is a valuable chemotherapeutic compound, but its use is associated with severe diarrhea in some patients. The CPT-11 prodrug is converted into the active 7-ethyl-10-hydroxycamptothecin (SN-38) metabo
Publikováno v:
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis, Vol 7, Iss 6, Pp 374-380 (2017)
Journal of Pharmaceutical Analysis, Vol 7, Iss 6, Pp 374-380 (2017)
A sensitive, rapid, simple and economical ultra-performance liquid chromatographyâtandem mass spectrometric method (UPLCâMS/MS) was developed and validated for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma using gl